Aureka Raises $100 Million for AI-Native Drug Discovery

Company: Aureka Biotechnologies · Event Type: Deal and Financing · Product/Asset: AuraIDE · Subject: AI Drug Discovery · Event Date: August 10, 2026 Summary Aureka Biotechnologies closed a $100 million Series B to expand biological foundation models, closed-loop automated experimentation and antibody-drug discovery. Granite Asia…